A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar i and bipolar II disorder

World Journal of Biological Psychiatry

Volumn 15, Issue 2, 2014, Pages 96-112

  Young, Allan H ^a   McElroy, Susan L ^b,c   Olausson, Bengt ^d   Paulsson, Björn ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LINDNER CENTER OF HOPE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

Antipsychotics; Bipolar I disorder; Bipolar II disorder; Depression; Quetiapine

Indexed keywords

CHOLESTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LITHIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PAROXETINE; PROLACTIN; QUETIAPINE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; PLACEBO;

ADULT; AGED; AKATHISIA; ARTICLE; ASTHENIA; BEDTIME DOSAGE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; CLINICAL LABORATORY; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DSM-IV; FATIGUE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPOMANIA; INSOMNIA; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REMISSION; RESTLESSNESS; RHINOPHARYNGITIS; SEDATION; SOMNOLENCE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; WEIGHT GAIN; XEROSTOMIA; YOUNG ADULT; YOUNG MANIA RATING SCALE; BIPOLAR DISORDER; CLASSIFICATION; RECURRENT DISEASE; TIME; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MALE; PLACEBOS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893868247     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2012.665177     Document Type: Article

References (25)

1. American Diabetes Association. 2006. Diagnosis and classifi cation of diabetes mellitus. Diabetes Care 29(Suppl 1):S43-48.
2. American Diabetes Association. 2011. Diagnosis and classifi cation of diabetes mellitus. Diabetes Care 34(Suppl 1):S62-69.
3. Barnes TR. 1989. A rating scale for drug-induced akathisia. Br J Psychiatry 154:672-676. (Pubitemid 19154942)
4. Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, et al. for the BOLDER Study Group. 2005. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162:1351-1360. (Pubitemid 40905587)
5. Daban C, Colom F, Sanchez-Moreno J, Garc í a-Amador M, Vieta E. 2006. Clinical correlates of fi rst-episode polarity in bipolar disorder. Compr Psychiatry 47:433-437. (Pubitemid 44602023)
6. Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV. 2006. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry 67:215-221. (Pubitemid 43357467)
7. Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Tsai-Dilsaver Y, Krajewski KJ. 1997. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 73:47-56. (Pubitemid 28032207)
8. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. 2004. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 161:217-222. (Pubitemid 38419270)
9. Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, et al. 2004. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432-441.
10. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
11. Keck PE Jr, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, et al.; Aripiprazole Study Group. 2007. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 68:1480-1491. (Pubitemid 350073394)
12. McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, et al.; for the EMBOLDEN II (Trial D1447C00134) Investigators. 2010. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 71:163-174.
13. Montgomery SA, Å sberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389. (Pubitemid 9136500)
14. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, et al. 2006. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 163:217-224. (Pubitemid 44480840)
15. Posner K, Oquendo MA, Gould M, Stanley B, Davies M. 2007. Columbia Classifi cation Algorithm of Suicide Assessment (C-CASA): classifi cation of suicidal events in the FDA ' s pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 164:1035-1043. (Pubitemid 47121392)
16. Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, et al. 2003. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 64:680-690. (Pubitemid 36750146)
17. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, et al. 2007. No health without mental health. Lancet 370:859-877. (Pubitemid 47371145)
18. Simpson GN, Angus JWS. 1970. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212(Suppl 44):11-19.
19. Suppes T, Vieta E, Liu S, Brecher M, Paulsson B, Trial 127 Investigators. 2009. Maintenance treatment in bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (Trial 127). Am J Psychiatry 166:476-488.
20. Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, et al; for the BOLDER II Study Group. 2006. Effi cacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (The BOLDER II Study). J Clin Psychopharmacol 26:600-609. (Pubitemid 44772737)
21. Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, et al. 2006. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 163:247-256. (Pubitemid 44480844)
22. Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M. 2008. Effi cacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 109: 251-263.
23. Weisler RH, Nolen WA, Neijber A, Hellqvist A, Paulsson B, Trial 144 Study Investigators. 2011. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized study). J Clin Psychiatry 72:1452-1464.
24. Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, et al.; for the EMBOLDEN I (Trial 001) Investigators. 2010. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 71:150-162.
25. Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435. (Pubitemid 9006756)